Sarah Krepp Sells 24,880 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) insider Sarah Krepp sold 24,880 shares of Liquidia stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $70.28, for a total value of $1,748,566.40. Following the sale, the insider owned 121,863 shares in the company, valued at $8,564,531.64. This represents a 16.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Sarah Krepp also recently made the following trade(s):

• On Monday, June 1st, Sarah Krepp sold 276 shares of Liquidia stock. The shares were sold at an average price of $60.87, for a total value of $16,800.12.
• On Monday, April 13th, Sarah Krepp sold 4,557 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total value of $174,852.09.

Liquidia Price Performance

Shares of NASDAQ LQDA opened at $68.01 on Wednesday. Liquidia Corporation has a twelve month low of $11.85 and a twelve month high of $73.22. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $6.05 billion, a price-to-earnings ratio of 485.82 and a beta of 0.58. The business has a 50 day simple moving average of $51.14 and a 200-day simple moving average of $41.50.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. The firm’s revenue for the quarter was up 4187.1% compared to the same quarter last year. As a group, equities research analysts expect that Liquidia Corporation will post 2.97 earnings per share for the current year.

Hedge Funds Weigh In On Liquidia

Several large investors have recently added to or reduced their stakes in the company. Covestor Ltd raised its holdings in shares of Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after buying an additional 359 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in Liquidia by 7.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after buying an additional 422 shares during the last quarter. Quantinno Capital Management LP boosted its position in shares of Liquidia by 3.6% in the 1st quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock worth $648,000 after purchasing an additional 589 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new position in shares of Liquidia in the 4th quarter worth $25,000. Finally, ProShare Advisors LLC boosted its position in shares of Liquidia by 7.1% in the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after purchasing an additional 775 shares during the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analyst Upgrades and Downgrades

LQDA has been the subject of a number of analyst reports. HC Wainwright boosted their price target on Liquidia from $67.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, June 5th. Raymond James Financial reissued a “strong-buy” rating and issued a $68.00 price objective on shares of Liquidia in a research note on Thursday, June 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a research note on Tuesday, April 21st. BTIG Research boosted their target price on Liquidia from $50.00 to $59.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Finally, Lifesci Capital raised Liquidia to a “strong-buy” rating in a research report on Thursday, March 5th. Three analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $60.29.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).